Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First NYSE-listed TCM Firm Faces Buyout

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Tongjitang Chinese Medicine Company has received a proposal letter for the acquisition of all the company's outstanding ordinary shares, which would make it a private company, the Shenzhen-based company announced on March 10
Advertisement

Related Content

Trade Secret Status Triggers Marketing Exclusivity For Chinese Drug Manufacturer
Trade Secret Status Triggers Marketing Exclusivity For Chinese Drug Manufacturer
Advertisement
UsernamePublicRestriction

Register

SC067913

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel